Clinical Trial Update: An Eight Week, Double-Blind Efficacy Study of Armodafinil Augmentation to Alleviate Fibromyalgia Fatigue [Phase 4]

View source ↗

Summary

Phase 4 double-blind trial assessing armodafinil augmentation to alleviate fatigue in fibromyalgia; the study is completed and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• NUVIGIL (armodafinil)
• armodafinil (generic)

Snippet

Sponsor: State University of New York - Upstate Medical University | Conditions: Fibromyalgia, Primary | Phase 4 | Status: COMPLETED | Results posted: 2014-12-18